These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2432424)

  • 21. Can the L5178Y Tk+/- mouse lymphoma assay detect epigenetic silencing?
    Cheng TF; Patton GW; Muldoon-Jacobs K
    Food Chem Toxicol; 2013 Sep; 59():187-90. PubMed ID: 23778052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hamster hepatocyte-mediated activation of procarcinogens to mutagens in the L5178Y/TK mutation assay.
    Amacher DE; Paillet SC
    Mutat Res; 1982 Dec; 106(2):305-16. PubMed ID: 7155171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutagenicity of rat-liver S9 to L5178Y mouse lymphoma cells.
    Myhr BC; Mayo JK
    Mutat Res; 1987 Sep; 189(1):27-37. PubMed ID: 3627149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preliminary molecular analysis of the TK locus in L5178Y large- and small-colony mouse lymphoma cell mutants.
    Cobb RR; Martin J; Korytynski E; Monteith L; Hughes TJ
    Mutat Res; 1989 Aug; 226(4):253-8. PubMed ID: 2761566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutagenicity and clastogenicity of teniposide (VM-26) in L5178Y/TK +/- -3.7.2C mouse lymphoma cells.
    DeMarini DM; Brock KH; Doerr CL; Moore MM
    Mutat Res; 1987 Mar; 187(3):141-9. PubMed ID: 3821767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A statistical method for analysis of mouse lymphoma L5178Y cell TK locus forward mutation assay. Comparison of results among three laboratories.
    Irr JD; Snee RD
    Mutat Res; 1982 Oct; 97(5):371-92. PubMed ID: 7144804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytogenetic analysis of the L5178Y/TK+/- leads to TK-/- mouse lymphoma mutagenesis assay system.
    Hozier J; Sawyer J; Moore M; Howard B; Clive D
    Mutat Res; 1981 Nov; 84(1):169-81. PubMed ID: 7329431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Responses of the L5178Y tk+/tk- mouse lymphoma cell forward mutation assay: III. 72 coded chemicals.
    McGregor DB; Brown A; Cattanach P; Edwards I; McBride D; Riach C; Caspary WJ
    Environ Mol Mutagen; 1988; 12(1):85-154. PubMed ID: 3383842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The induction and characterization of mouse lymphoma L5178Y cell lines resistant to 1-beta-d-arabinofuranosylcytosine.
    Rogers AM; Hill R; Lehmann AR; Arlett CF; Burns VW
    Mutat Res; 1980 Jan; 69(1):139-48. PubMed ID: 7360142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trifluorothymidine resistance and colony size in L5178Y/TK +/- cells treated with methyl methanesulfonate.
    Amacher DE; Paillet SC
    J Cell Physiol; 1981 Mar; 106(3):349-60. PubMed ID: 6783669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Responses of the L5178Y tk+/tk- mouse lymphoma cell forward mutation assay. II: 18 coded chemicals.
    McGregor DB; Brown A; Cattanach P; Edwards I; McBride D; Caspary WJ
    Environ Mol Mutagen; 1988; 11(1):91-118. PubMed ID: 3338442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mutagenic potency of 1,8-dinitropyrene in cultured mouse lymphoma cells.
    Cole J; Arlett CF; Lowe J; Bridges BA
    Mutat Res; 1982 Mar; 93(1):213-20. PubMed ID: 6801506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Locus specificity of mutagenicity of 2,4-diaminotoluene in both L5178Y mouse lymphoma and AT3-2 Chinese hamster ovary cells.
    Coppinger WJ; Brennan SA; Carver JH; Thompson ED
    Mutat Res; 1984 Feb; 135(2):115-23. PubMed ID: 6694660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. L5178Y mouse lymphoma cell mutation assay results with 41 compounds.
    Myhr B; McGregor D; Bowers L; Riach C; Brown AG; Edwards I; McBride D; Martin R; Caspary WJ
    Environ Mol Mutagen; 1990; 16 Suppl 18():138-67. PubMed ID: 2128695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells. II. Test validation and interpretation.
    Amacher DE; Paillet SC; Turner GN; Ray VA; Salsburg DS
    Mutat Res; 1980 Aug; 72(3):447-74. PubMed ID: 7453708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mouse lymphoma L5178Y thymidine kinase locus assay of 50 compounds.
    Wangenheim J; Bolcsfoldi G
    Mutagenesis; 1988 May; 3(3):193-205. PubMed ID: 3045481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between topoisomerase II and radiosensitivity in mouse L5178Y lymphoma strains.
    Evans HH; Ricanati M; Horng MF; Mencl J
    Mutat Res; 1989 Jan; 217(1):53-63. PubMed ID: 2536134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of the soft agar and microtitre methodologies for the L5178Y tk +/- mouse lymphoma assay.
    Oberly TJ; Yount DL; Garriott ML
    Mutat Res; 1997 Jan; 388(1):59-66. PubMed ID: 9025792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutagenicity and clastogenicity of adriamycin in L5178Y/TK(+/-)-3.7.2C mouse lymphoma cells.
    Moore MM; Brock KH; Doerr CL; DeMarini DM
    Mutat Res; 1987; 191(3-4):183-8. PubMed ID: 3627155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of L5178Y mouse lymphoma cells to assess the mutagenic, clastogenic and aneugenic properties of chemicals.
    Combes RD; Stopper H; Caspary WJ
    Mutagenesis; 1995 Sep; 10(5):403-8. PubMed ID: 8544753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.